• A case of T-cell acute lymphoblastic leukemia in retroviral gene therapy for ADA-SCID
• A case report on deficiency of adenosine deaminase 2 with relapse-remission course and analysis of genotype-phenotype correlation
• A case series of ten plus one deficiency of adenosine deaminase 2 (DADA2) patients in Iran
• A case with febrile attacks and vasculopathy associated with ADA2 and MEFV pathogenic variants
• A Clinical Neurological Approach to the Child With Adenosine Deaminase Deficiency
• A Narrative Review of the Neurological Manifestations of Human Adenosine Deaminase 2 Deficiency
• A new CECR1 mutation associated with severe hematological involvement in ADA2 deficiency
• ADA2 regulates inflammation and hematopoietic stem cell emergence via the A_2bR pathway in zebrafish
• Adenosine Deaminase 2 Deficiency Caused by Biallele Variants Including Splicing Variant: The First Case in Korea
• Adenosine deaminase 2 deficiency in a Chinese patient: Report of one novel mutation and literature review
• Adenosine Deaminase Deficiency
• AMPD2 plays important roles in regulating hepatic glucose and lipid metabolism
• Brainstem Infarction in Immunodeficiency Identified as Adenosine Deaminase 2 Deficiency: Case Report
• Case Report: Patient with deficiency of ADA2 presenting leukocytoclastic vasculitis and pericarditis during infliximab treatment
• Composition, structure, and functional shifts of prokaryotic communities in response to co-composting of various nitrogenous green feedstocks
• Cutaneous vasculitis in autoinflammatory diseases
• Deficiency of ADAR2 ameliorates metabolic-associated fatty liver disease via AMPK signaling pathways in obese mice
• Deficiency of adenosine deaminase 2 (DADA2) presenting with diffuse skeletal muscle vasculitis
• Deficiency of adenosine deaminase 2 (DADA2): Review
• Deficiency of adenosine deaminase 2: a genetic autoinflammatory disorder mimicking childhood polyarteritis nodosa
• Delayed-onset adenosine deaminase deficiency with a novel synonymous mutation and a case series from China
• Development of EBV Related Diffuse Large B-cell Lymphoma in Deficiency of Adenosine Deaminase 2 with Uncontrolled EBV Infection
• Editorial: Frontiers in diagnostic and therapeutic approaches in diabetic sensorimotor neuropathy
• Gene therapy for adenosine deaminase severe combined immune deficiency-An unexpected journey of four decades
• Hemophagocytic inflammatory syndrome in ADA-SCID: report of two cases and literature review
• Hepatocellular Carcinoma in ADA-SCID Patient After Hematopoietic Stem Cell Transplantation
• Infliximab as successful treatment option in a case of adenosine deaminase 2 deficiency
• Ischaemic cerebral small vessel disease caused by adenosine deaminase 2 deficiency syndrome
• Kidney Involvement in Autoinflammatory Diseases
• Long-term and real-world safety and efficacy of retroviral gene therapy for adenosine deaminase deficiency
• Long-Term Immune Reconstitution in ADA-Deficient Patients Treated With Elapegademase: A Real-World Experience
• Metagenomic profiling pipelines improve taxonomic classification for 16S amplicon sequencing data
• National experience with adenosine deaminase deficiency related SCID in Polish children
• Negative features of sporadic amyotrophic lateral sclerosis: Motor neurons of Onuf's nucleus survive in ADAR2-conditional knockout mice
• Neurological phenotype of ADA2 deficient patients: a cohort study
• Neurological phenotype of adenosine deaminase 2 deficient patients: a cohort study
• Novel ADA2 Variants in a Romanian Case Series of DADA2
• Omenn Syndrome can Occur during Enzyme Therapy for Adenosine Deaminase Deficiency
• Optimized expression and purification of a human adenosine deaminase in E. coli and characterization of its Asp8Asn variant
• Outcome of BCG Vaccination in ADA-SCID Patients: A 12-Patient Series
• PEGylated Recombinant Adenosine Deaminase Maintains Detoxification and Lymphocyte Counts in Patients with ADA-SCID
• Proposal for a Disease Activity Score and Disease Damage Score for ADA2 Deficiency: the DADA2AI and DADA2DI
• Recurrent flare-associated urticaria in adenosine deaminase type 2 deficiency
• Safety and efficacy of elapegademase in patients with adenosine deaminase deficiency: A multicenter, open-label, single-arm, phase 3, and postmarketing clinical study
• Severe combined immunodeficiency diagnosis and genetic defects
• Severe combined immunodeficiency: improved survival leading to detection of underlying liver disease
• Successful management of delayed-onset adenosine deaminase deficiency with novel mutation
• TNF-Blockade for Primary Stroke Prevention in Adenosine Deaminase 2 Deficiency: A Case Series
• Transamniotic Fetal Administration of Genetically Modified Hematopoietic Stem Cells Carrying a Human Transgene in a Syngeneic Rat Model
• Treatment with Elapegademase Restores Immunity in Infants with Adenosine Deaminase Deficient Severe Combined Immunodeficiency
• Two Unrelated Iranian Patients with Adenosine Deaminase 2 Deficiency: A Case Report and Review of Treatment
• Updated Management Guidelines for Adenosine Deaminase Deficiency
• Vasculitis associated with adenosine deaminase 2 deficiency: at the crossroads between Behçet's disease and autoinflammation. A viewpoint
• What a Clinician Needs to Know About Genome Editing: Status and Opportunities for Inborn Errors of Immunity
• Whole Exome Sequencing Reveals Pathogenic Variants in ADA2 and FAS Causing DADA2 and ALPS